WARD COPD

Study design
Prospective study/cohort
Sample size
200 participants
Study sites

Bispebjerg Hospital and Gentofte Hospital

Inclusion criteria
  • Adult patients admitted with AECOPD
  • Recruitment and monitoring start is possible within 24 hours after admission
Study procedures

Wearable devices recorded vital signs during the first four days of admission. Researchers related abnormal readings to serious adverse events within 30 days. Usual clinical care continued.

Results

SAE during ongoing continuous monitoring occurred in 50 patients (25%). Patients suffering SAE during the monitoring period had on average 455 min (SD 413) per 24 h of any preceding vital sign abnormality versus 292 min (SD 246) in patients without SAE, p = 0.08, mean difference 163 min [95% CI 61–265]. Mean duration of bradypnea (respiratory rate < 11 min−1) was 48 min (SD 173) compared with 30 min (SD 84) in patients without SAE, p = 0.01.

Outcome

50 of 200 patients experienced a serious adverse event during monitoring. The overall duration of preceding vital sign abnormalities did not differ significantly between patients with and without these events. Slow breathing was more prolonged before serious events.

Trial registration
NCT03660501

–  Read more